Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
Felix Mueller, Claudia Lenz, Patrick C. Dolder, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 4, pp. e1084-e1084
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Psychedelics and Psychedelic-Assisted Psychotherapy
Collin Reiff, Elon E. Richman, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 5, pp. 391-410
Closed Access | Times Cited: 462
The entropic brain - revisited
Robin Carhart‐Harris
Neuropharmacology (2018) Vol. 142, pp. 167-178
Closed Access | Times Cited: 437
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 418
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia‐Romeu, Alan K. Davis, Fire Erowid, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1088-1101
Closed Access | Times Cited: 231
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 209
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid, Matthias E. Liechti
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 535-545
Open Access | Times Cited: 201
Modern Clinical Research on LSD
Matthias E. Liechti
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2114-2127
Open Access | Times Cited: 198
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 891-900
Open Access | Times Cited: 191
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Rafael G. dos Santos, José Carlos Bouso, Miguel Ángel Alcázar‐Córcoles, et al.
Expert Review of Clinical Pharmacology (2018) Vol. 11, Iss. 9, pp. 889-902
Closed Access | Times Cited: 190
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 190
A systematic study of microdosing psychedelics
Vince Polito, Richard J. Stevenson
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0211023-e0211023
Open Access | Times Cited: 179
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 163
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Lisa Burback, Suzette Brémault‐Phillips, Mirjam J. Nijdam, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 4, pp. 557-635
Closed Access | Times Cited: 98
Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses
Drummond E-Wen McCulloch, Gitte M. Knudsen, Frederick S. Barrett, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 138, pp. 104689-104689
Open Access | Times Cited: 80
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field
Vince Polito, Paul Liknaitzky
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104706-104706
Open Access | Times Cited: 74
Psychedelic Drugs in Biomedicine
Evan J. Kyzar, Charles D. Nichols, Raul R. Gainetdinov, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 11, pp. 992-1005
Closed Access | Times Cited: 139
Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers
Anya K. Bershad, Scott T. Schepers, Michael P. Bremmer, et al.
Biological Psychiatry (2019) Vol. 86, Iss. 10, pp. 792-800
Open Access | Times Cited: 138
Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms
Rafael G. dos Santos, Jaime E. C. Hallak
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 423-434
Closed Access | Times Cited: 110
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses
Tingying Chi, Jessica A. Gold
Journal of the Neurological Sciences (2020) Vol. 411, pp. 116715-116715
Open Access | Times Cited: 77
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 69
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder
Rafael G. dos Santos, Flávia de Lima Osório, Juliana Mendes Rocha, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 5, pp. 540-550
Closed Access | Times Cited: 66
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
Danilo De Gregorio, Antonio Inserra, Justine P. Enns, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 6, pp. 1188-1198
Open Access | Times Cited: 63
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review
Bruno Roméo, Marianne Hermand, Amélie Petillion, et al.
Journal of Psychiatric Research (2021) Vol. 137, pp. 273-282
Open Access | Times Cited: 61
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 876-917
Open Access | Times Cited: 59
Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation
Sanket B. Raut, Padmaja A Marathe, Liza van Eijk, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108195-108195
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top